Clinical Trial Update: The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effect of Byetta (exenatide) and Symlin (pramlintide) on post-meal blood glucose in children with Type 2 diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)
• Symlin (pramlintide)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED